Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04343391
Other study ID # Brief-Psychotherapies
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2020
Est. completion date October 15, 2020

Study information

Verified date November 2020
Source Universidad de Córdoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present work aims to develop a randomized clinical trial with a sample of 150 patients diagnosed with at least one of the following emotional disorder: somatoform disorder, panic disorder, generalized anxiety disorder and depression disorder. Participants are tested by several self-reports related to the emocional disorders mentioned in a repeated measures design, pre and post treatment. The investigators think this study will demonstrate that brief psychological treatments should be prioritized over pharmacological treatment for such pathologies in the Primary or Secondary Care context to improve the patient´s quality of life.


Description:

Nowadays, the heavy demands placed on health systems exceed the resources in many developed countries. So-called "emotional disorders" and their mostly pharmacological treatment are, in no small part, responsible for this situation. However, research indicates that psychological treatment should be the first step when caring for these types of problems. The investigators expect that the results show that brief psychological therapies are more effective than pharmacological interventions. Moreover, it is expected that brief individual psychotherpay approach delivered in secondary care is more effective than brief group psychotherapy delivered in primary care.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date October 15, 2020
Est. primary completion date October 15, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Emotional Disorder Exclusion Criteria: - Severe mental disorder - Substance use disorder - Severe depression

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Brief transdiagnostic cognitive-behavioral therapy
Time-limited transdiagnostic evidence-based psychological treatment
Drug:
Pharmacological treatment
Treatment as usual in PC

Locations

Country Name City State
Spain Universidad de Córdoba Cordoba Córdoba

Sponsors (2)

Lead Sponsor Collaborator
Universidad de Córdoba Ministerio de Economía y Competitividad, Spain

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Health Questionnaire (PHQ-15) The Patient Health Questionnaire-Somatoform Disorder is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.The PHQ-15 is the somatization module, which scores each DSM-IV criteria as "0" (not bothered at all) to "2" (bothered a lot). The more score the more severity. 10 weeks
Primary State-Trait Anxiety Inventory (STAI) The State-Trait Anxiety Inventory is a commonly used measure of trait and state anxiety (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It also is often used in research as an indicator of caregiver distress AnxietyForm Y, its most popular version, has 20 items for assessing trait anxiety and 20 for state anxiety. All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety. The STAI is appropriate for those who have at least a sixth-grade reading level. Internal consistency coefficients for the scale have ranged from .86 to .95; test-retest reliability coefficients have ranged from .65 to .75 over a 2-month interval (Spielberger et al., 1983). 10 weeks
Primary Beck Depression Inventory (BDI-II) The Beck Depression Inventory (second edition) is a widely used 21-item self-report inventory measuring the severity of depression in adolescents and adults. The BDI-II was revised in 1996 to be more consistent with DSM-IV criteria for depression. For example, individuals are asked to respond to each question based on a two-week time period rather than the one-week timeframe on the BDI. The BDI-II is widely used as an indicator of the severity of depression, but not as a diagnostic tool, and numerous studies provide evidence for its reliability and validity across different populations and cultural groups. The more score the more depression severity. 10 weeks
Primary Patient Health Questionnaire (PHQ-9) The Patient Health Questionnaire-Depression is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The more score the more severity. 10 weeks
Primary Patient Health Questionnaire (PHQ-PD) The Patient Health Questionnaire-Panic Disorder is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.The PHQ-PD is the panic disorder module, which scores each DSM-IV criteria as "yes" or "no". Higher scores mean greater severity of panic disorder. 10 weeks
Primary Generalized Anxiety Disorder score (GAD-7) The Generalized Anxiety Disorder score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater. Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD. 10 weeks
Primary Brief Symptom Inventory (BSI-18) The Brief Symptom Inventory contains the three six-item scales somatization, depression, and anxiety as well as the Global Severity Index (GSI), including all 18 items. The BSI-18 is the latest and shortest of the multidimensional versions of the Symptom-Checklist 90-R. The more score the more symptoms patients report. 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Active, not recruiting NCT04935593 - Strengthening Social, Emotional and Behavioral Resilience N/A
Not yet recruiting NCT05225701 - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders. N/A
Recruiting NCT05172427 - Acceptability/Feasibility of IU Intervention N/A
Recruiting NCT03064477 - The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System N/A
Recruiting NCT05019053 - Acceptability/Feasibility of COVID-19 Intervention N/A
Active, not recruiting NCT04847310 - Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care N/A
Completed NCT04091633 - School Health Implementation Network: Eastern Mediterranean N/A
Not yet recruiting NCT06056232 - Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation N/A
Recruiting NCT06105567 - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress N/A
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT05589090 - Super Skills for Life Effectiveness in the Online Modality N/A
Completed NCT03315208 - Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders N/A
Completed NCT03312673 - Asthma, Smoking, Emotional Deficits
Completed NCT04182061 - Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents N/A
Not yet recruiting NCT05081830 - Online Transdiagnostic Intervention for Emotional Disorders and Stress-related Disorders N/A
Completed NCT04137471 - Validation of the Ontological Addiction Scale
Completed NCT05482724 - Super Skills for Life Effectiveness in Clinical Settings N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT06361667 - Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") N/A